In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster session I
Session

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

Topic : Imaging

  • Session type : Poster Session
  • Date : 12 May 2019
  • Time : 11:00 - 19:30

45 presentations in this session

Current utility and provision of FFRCT

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : A Asher (London,GB)

The effect of myocardial bridge on the amount of atherosclerotic plaques and on the local hemodynamic changes

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : S Borzsak (Budapest,HU)

On-site coronary CT - derived FFR for the assessment of non-culprit lesions in patients who suffered myocardial infarction

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : J Simon (Budapest,HU)

Reproducibility of CT patterns of right ventricular dysfunction in patients with acute pulmonary embolism

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : S Minin (Novosibirsk,RU)

Experience of use of heart MRI in differential diagnostics pericardial and cardiac mass

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : AA Malov (Kazan,RU)

Cardiac contractile and sympathetic activity in patients with ischemic and non-ischemic chronic heart failure

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : K Zavadovskiy (Tomsk,RU)

Texture analysis of myocardial perfusion SPECT with a digital cardiac phantom

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : K Okuda (Ishikawa,JP)

Impact of pre-test probability of CAD in post-test probability by Myocardial Perfusion Scintigraphy

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : RA Guerreiro (Evora,PT)

Relationship between persistent ST elevation and dyskinesia assessed by gated-SPECT

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : E Alexanderson Rosas (Mexico,MX)

Appropriate Use of Stress Myocardial Perfusion Scan One year study from a stand alone Nuclear Imaging centre

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : K Kumaresan (Hyderabad,IN)

Pharmacologic stress SPECT. Are we properly selecting patients for invasive evaluation?

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : N Casanovas (Badalona,ES)

Evaluation of perfusion reserve in patients with postinfarction cardiosclerosis complicated by severe chronic heart failure

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : ZD Rasulova (Tashkent,UZ)

Depression and anxiety in patients subjected to diagnostic myocardial perfusion imaging

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : C Sioka (Ioannina,GR)

Echocardiography and 99mTc-DPD scintigraphy on cardiac amyloidosis investigation

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : C Domingues (Monte Redondo,PT)

Trends in frequency of stress induced ischemia in myocardial perfusion imaging in a southeast asian population.

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : Z Huang (Singapore,SG)

Does prone position impact on quantitative parameters of MPI SPECT assessment?

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : L Louw (Johannesburg,ZA)

18F-FDG uptake in the wall of the atria: can we find a simple explanation?

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : C Domingues (Monte Redondo,PT)

Advance texture analysis: a new step in imaging of IE?

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : R Zanca (Pisa,IT)

Comparative assessment of [18F] FDG, [18F]NaF and 68Ga-DOTATATE imaging in patients with symptomatic carotid stenosis

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : R Zanca (Pisa,IT)

18F-FDG uptake in the right atrium in patients with heart failure

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : C Domingues (Monte Redondo,PT)

The influence of patient motion on the quantitative accuracy of dynamic cardiac 15O-water PET/CT

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : J Nordstrom (Gavle,SE)

Novel echocardiographic indices and biomarkers in the evaluation of patients with pulmonary hypertension due to left heart disease

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : D Kristo (Thessaloniki,GR)

Implementation of a modern non-invasive diagnostic strategy in the diagnosis of coronary artery disease

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : A van der Hoorn (Alkmaar,NL)

Systolic right ventricle dysfunction in oncological patients treated with cardiotoxic drugs.

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Session : Poster session I
  • Speaker : S Aguade-Bruix (Barcelona,ES)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are